LEO Pharma's Anzupgo cream receives European marketing approval for adults with moderate to severe chronic hand eczema
LEO Pharma A/S, a global leader in medical dermatology, announced that the European Commission (EC) has granted marketing authorization for Anzupgo (delgocitinib) cream for the treatment of adult patients with moderate to severe chronic hand eczema ( …